GSK Investigational Site

Žamberk 564 01

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease — Completed